All fields · Endocrinology, Diabetes and Metabolism

JournalQ1· SCImago 2025

New England Journal of Medicine

ISSN 0028-4793

• Q1Quartile
• 18.00SJR
• 1275h-index
• 376papers summarised

About this journal

New England Journal of Medicine is a Q1 journal by SCImago Journal Rank (2025 data), with an SJR of 18.00 and an h-index of 1275. Most of its papers in the Pofolia pool fall under Endocrinology, Diabetes and Metabolism. Pofolia holds AI summaries of 376 paper(s) from this journal; the most cited is “Clinical Characteristics of Coronavirus Disease 2019 in China” (31181 citations).

The quartile (Q1–Q4) is the journal's percentile position within its subject area by SCImago Journal Rank; Q1 is the top 25%. What is a Q1 journal?

Papers we summarise from this journal

• Clinical Characteristics of Coronavirus Disease 2019 in China2020 · 31181 citations
• A Novel Coronavirus from Patients with Pneumonia in China, 20192020 · 30418 citations
• Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma2005 · 21799 citations
• Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia2020 · 17975 citations
• Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020 · 15595 citations
• Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer2012 · 12708 citations
• Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015 · 12062 citations
• Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine2020 · 10782 citations
• Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-12020 · 10226 citations
• Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer2016 · 10140 citations
• Dexamethasone in Hospitalized Patients with Covid-192020 · 10118 citations
• PD-1 Blockade in Tumors with Mismatch-Repair Deficiency2015 · 9492 citations
• Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer2015 · 9485 citations
• Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer2015 · 8585 citations
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma2015 · 8184 citations
• Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer2012 · 8030 citations
• Health Effects of Overweight and Obesity in 195 Countries over 25 Years2017 · 7990 citations
• Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing2012 · 7822 citations
• Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017 · 7801 citations
• Remdesivir for the Treatment of Covid-19 — Final Report2020 · 7738 citations
• Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016 · 7419 citations
• Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma2020 · 7315 citations
• Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction2019 · 6927 citations
• Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure2014 · 6869 citations
• Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine2013 · 6697 citations
• Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016 · 6673 citations
• Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer2018 · 6647 citations
• A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke2014 · 6632 citations
• First Case of 2019 Novel Coronavirus in the United States2020 · 6399 citations
• Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes2018 · 6343 citations

Journals in the same field

See every journal in the field →